The Berkson Clinical Study

The whole article, written by an American physician Dr. Burton Berkson, is
available for your review at
http://www.healthyhepper.com/berksonclinicalstudy.htm


ABSTRACT
There are no remarkably effective treatments for chronic hepatitis C in general
use, Interferon and antiviral have less than a 30% response rate and because of
the residual viremia, a newly transplanted liver usually becomes infected again.
The triple antioxidant combination of alpha-lipoic acid, silymarin and selenium
was chosen for a conservative treatment of hepatitis C because these substances
protect the liver from free radical damage, increase the levels of other
fundamental antioxidants, and interfere with viral proliferation. The 3 patients
presented in this paper followed the tripleantioxidant program and recovered
quickly and their laboratory values remarkably improved. Furthermore, liver
transplantation was avoided and the patients are back at work, carrying out
their normal activities, and feeling health. The author offers a more
conservative approach to the treatment of hepatitis C, that is exceedingly less
expensive. One year of the triple antioxidant therapy described in this paper
costs less than $2,000, as compared to more than $300,000 a year of liver
transplant surgery. It appears reasonable, that prior to liver transplant
surgery evaluation, or during the transplant evaluation process, the
conservative triple antioxidant treatment approach should be considered. If
there is a significant betterment in the patient's condition, liver transplant
surgery may be avoided.

The whole article, written by an American physician Dr. Burton Berkson, is
available for your review at
http://www.healthyhepper.com/berksonclinicalstudy.htm